These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 27743577

  • 1. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J, Goldberg RJ.
    Am J Cardiol; 2016 Dec 15; 118(12):1792-1797. PubMed ID: 27743577
    [Abstract] [Full Text] [Related]

  • 2. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M, Alagna M, Lallo A, Gilmore KJ, Francesconi P, Profili F, Scondotto S, Fantaci G, Trifirò G, Isgrò V, Davoli M, Fusco D.
    BMC Cardiovasc Disord; 2021 Apr 14; 21(1):180. PubMed ID: 33853534
    [Abstract] [Full Text] [Related]

  • 3. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Barón AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K.
    Circ Cardiovasc Qual Outcomes; 2019 Nov 14; 12(11):e005455. PubMed ID: 31665896
    [Abstract] [Full Text] [Related]

  • 4. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
    Bruggmann C, Iglesias JF, Gex-Fabry M, Fesselet R, Vogt P, Sadeghipour F, Voirol P.
    Am J Cardiovasc Drugs; 2020 Feb 14; 20(1):105-115. PubMed ID: 31300969
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM.
    Heart; 2015 May 15; 101(10):800-7. PubMed ID: 25801001
    [Abstract] [Full Text] [Related]

  • 6. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM.
    Am Heart J; 1999 Jan 15; 137(1):79-92. PubMed ID: 9878939
    [Abstract] [Full Text] [Related]

  • 7. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K, Yasuda S, Nishimura K, Noguchi T, Nakai M, Miyamoto Y, Sumita Y, Shishido T, Anzai T, Ito H, Tsutsui H, Saito Y, Komuro I, Ogawa H.
    J Am Heart Assoc; 2019 Apr 02; 8(7):e009692. PubMed ID: 30909774
    [Abstract] [Full Text] [Related]

  • 8. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C, Du J, Li X, Li J, Zhang H, Zhao Y, Hu S, Jiang L, Zheng Z, MISSION-1 Collaborative Group.
    Am Heart J; 2016 Aug 02; 178():9-18. PubMed ID: 27502847
    [Abstract] [Full Text] [Related]

  • 9. Management, hospital outcome and revascularization trends in non-ST elevation myocardial infarction with high GRACE risk score.
    Akhter Z, Rind IA, Aijaz S, Sattar S, Malik R, Pathan A.
    J Pak Med Assoc; 2019 Oct 02; 69(10):1486-1492. PubMed ID: 31622302
    [Abstract] [Full Text] [Related]

  • 10. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS, Saad A, Al-Suwaidi J, Al-Marridi WZ, Elkhalifa DH, Mohamed AA, Mahfoud ZR.
    Curr Vasc Pharmacol; 2016 Oct 02; 14(4):394-403. PubMed ID: 26916397
    [Abstract] [Full Text] [Related]

  • 11. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 12. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH, Pereg D, Lishner M, Elis A.
    Harefuah; 2015 May 15; 154(5):299-302, 339-40. PubMed ID: 26168639
    [Abstract] [Full Text] [Related]

  • 13. Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Harrison RW, Simon D, Miller AL, de Lemos JA, Peterson ED, Wang TY.
    Am Heart J; 2016 Aug 15; 178():95-101. PubMed ID: 27502856
    [Abstract] [Full Text] [Related]

  • 14. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E.
    BMC Cardiovasc Disord; 2016 May 31; 16():115. PubMed ID: 27246583
    [Abstract] [Full Text] [Related]

  • 15. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B, Musić L, Batrićević G, Bošković A, Bulatović N, Nenezić A, Vujović J, Kalezić M.
    Int J Cardiol; 2016 Aug 31; 217 Suppl():S32-6. PubMed ID: 27381861
    [Abstract] [Full Text] [Related]

  • 16. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
    Amann U, Kirchberger I, Heier M, Thilo C, Kuch B, Meisinger C.
    Eur J Intern Med; 2018 Jan 31; 47():62-68. PubMed ID: 28826823
    [Abstract] [Full Text] [Related]

  • 17. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.
    Hao Y, Liu J, Liu J, Smith SC, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Zhang Q, Wang W, Zhao D, CCC-ACS Investigators.
    Am Heart J; 2016 Sep 31; 179():107-15. PubMed ID: 27595685
    [Abstract] [Full Text] [Related]

  • 18. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV, Michaels AD, Maynard C, Every NR.
    J Am Coll Cardiol; 1998 Aug 31; 32(2):360-7. PubMed ID: 9708461
    [Abstract] [Full Text] [Related]

  • 19. Changing Trends in the Landscape of Patients Hospitalized With Acute Myocardial Infarction (2001 to 2011) (from the Worcester Heart Attack Study).
    Mercado-Lubo R, Yarzebski J, Lessard D, Gore J, Goldberg RJ.
    Am J Cardiol; 2020 Mar 01; 125(5):673-677. PubMed ID: 31924320
    [Abstract] [Full Text] [Related]

  • 20. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
    Soldati S, Di Martino M, Rosa AC, Fusco D, Davoli M, Mureddu GF.
    BMC Cardiovasc Disord; 2021 Sep 27; 21(1):466. PubMed ID: 34565326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.